NCT01718093 A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT01717911 ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate Hyperglycemia Status UNKNOWN Phase PHASE4
NCT01717482 Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT01717313 A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011) Status COMPLETED Phase PHASE3
NCT01709305 A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) Status COMPLETED Phase PHASE4
NCT01704261 Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022) Status COMPLETED Phase PHASE3
NCT01702298 A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312) Status COMPLETED Phase PHASE3
NCT01686126 Improving the Treatment for Women With Early Stage Cancer of the Uterus Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01685762 Metformin for the Treatment of Endometrial Hyperplasia Status COMPLETED Phase EARLY_PHASE1
NCT01682759 A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016) Status COMPLETED Phase PHASE3
NCT01681693 Effect of Genetic Variants in MATE1 and OCT3 on the Pharmacodynamics of Metformin in African Americans Status COMPLETED Phase PHASE1
NCT01681680 Effect of Genetic Variation in the Transporter OCT2, MATE1 and MATE2-K on the PKPD of Metformin Status COMPLETED Phase PHASE1
NCT01679574 Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome Status COMPLETED Phase NA
NCT01678820 A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266) Status TERMINATED Phase PHASE3
NCT01677923 Obesity in Children and Adolescents: Associated Risks and Early Intervention Status COMPLETED Phase PHASE3
NCT01677897 Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT01672788 Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets Status COMPLETED Phase PHASE1
NCT01666665 Mechanisms of Improved Wound Healing and Protein Synthesis of Insulin and Metformin Status TERMINATED Phase PHASE2/PHASE3
NCT01664845 Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin Resistance Status UNKNOWN Phase PHASE2/PHASE3